Exponent, Inc. (NASDAQ: EXPO) is a Industrials company (Engineering & Construction) with a market capitalization of $4.2B. The Maz Rating grades it against the other companies in its sector.
About three months ago (August 17, 2026), Exponent, Inc. had a Maz Rating of 3.21 out of 5 (B+, Buy), ranked against the other companies in its sector. Its strongest factor then was Profitability (4.56), among the strongest in its sector; its weakest was Valuation (1.63), more expensive than most of its sector. The other factors: Financial Health 4.52 (among the strongest in its sector); Momentum 2.98 (around the middle of its sector); Growth 2.65 (around the middle of its sector). The current rating is for members: log in to see it.
At $87.69, Exponent, Inc. trades at 37.8x trailing earnings, 6.3x sales and 13.7x book value, with an EV/EBITDA of 26.2. Over the last twelve months it generated about $659M of revenue and $110M of net income. It runs a gross margin of 25.5%, an operating margin of 21.3% and a net margin of 17.4%. It shows return on equity of 34.6%, return on invested capital of 19.4% and a free cash flow yield of 3.4%. On the balance sheet: a debt-to-equity ratio of 0.26 and a current ratio of 1.94. Over the past 52 weeks the share price ranged from $51.91 to $90.51, with a beta of 0.68.
Exponent, Inc. pays a dividend yielding 1.40%, with 53% of earnings paid out. Its Maz Dividend Score is 2.00 out of 5, ranked against the other dividend payers in its sector (Safety 1.89, Growth 3.37, Yield 2.37, Consistency 3.49).
8 Wall Street analyst ratings cover the stock: 6 Buy and 2 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Exponent, Inc. functions as a global leader in scientific and engineering consulting, operating through its subsidiaries. The firm's activities are divided into two principal segments: Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific division offers a broad spectrum of services encompassing biomechanics, biomedical sciences, structural analysis, civil engineering, construction advisory, data analytics, electrical and computer science, human factors, materials and corrosion science, mechanical engineering, polymer chemistry, thermal dynamics, and vehicle system engineering. Concurrently, the Environmental and Health segment specializes in areas such as chemical regulatory compliance, food safety, ecological and biological studies, earth and environmental sciences, and various health-related scientific fields. With expertise spanning approximately 90 technical disciplines, Exponent is dedicated to addressing complex and pressing issues for its stakeholders. Its client base is diverse, covering industries like chemicals, construction, consumer products, energy, food and beverage, government, life sciences, insurance, manufacturing, technology, heavy industrial equipment, and transportation. The company, originally established in 1967 as The Failure Group, Inc., rebranded as Exponent, Inc. in 1998, and its headquarters are located in Menlo Park, California.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
It depends on the standard you follow. As of October 2026, Exponent, Inc. (EXPO) passes 4 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global, Dow Jones and MSCI, and fails FTSE.
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 0.00% / 30% · (Cash+Inv) / Mkt Cap (36m) 3.23% / 30% · Interest income / Revenue 0.38% / 5% | Pass |
| S&P Global | Debt / Mkt Cap (36m) 0.00% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 3.23% / 33% · Receivables / Mkt Cap (36m) 5.91% / 49% · Interest income / Revenue 0.38% / 5% | Pass |
| Dow Jones | Debt / Mkt Cap (24m) 0.00% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 3.23% / 33.33% · Receivables / Mkt Cap (24m) 5.91% / 33.33% · Interest income / Revenue 0.38% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 0.24% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 18.6% / 33.33% · Receivables / Avg Assets (4Q) 28.7% / 33.33% · Interest income / Revenue 0.38% / 5% | Pass |
| FTSE | Debt / Total Assets 0.00% / 33.33% · (Cash+ST Inv) / Total Assets 16.5% / 33.33% · (Cash+Recv) / Total Assets 46.8% / 33.33% · Interest income / Revenue 0.38% / 5% | Fail |
It depends on the standard you follow. As of October 2026, Exponent, Inc. (EXPO) passes 4 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global, Dow Jones and MSCI, and fails FTSE.
Yes. Exponent, Inc. is within every AAOIFI limit: debt and interest-bearing cash and investments under 30% of its 36-month average market cap, and interest income under 5% of revenue.
About 0.38% of each dividend: Exponent, Inc.'s interest income as a share of its revenue. Give that share to charity; the dividend purification calculator works it out per holding.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated October 2, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.